These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31705294)

  • 21. Identification of potential serum biomarkers for simultaneously classifying lung adenocarcinoma, squamous cell carcinoma and small cell carcinoma.
    Yu J; Du F; Yang L; Chen L; He Y; Geng R; Wu L; Xie B
    Cancer Biomark; 2021; 30(3):331-342. PubMed ID: 33361584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung cancer recurrence and mortality outcomes over a 10-year period using a multidisciplinary team approach.
    Nemesure B; Albano D; Bilfinger T
    Cancer Epidemiol; 2020 Oct; 68():101804. PubMed ID: 32896806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of seventh TNM and eighth TNM staging system in stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy.
    Yılmaz U; Özdemir Ö; Yılmaz Ü
    Curr Probl Cancer; 2019 Feb; 43(1):33-42. PubMed ID: 29804944
    [No Abstract]   [Full Text] [Related]  

  • 25. Decreased sphingomyelin (t34:1) is a candidate predictor for lung squamous cell carcinoma recurrence after radical surgery: a case-control study.
    Takanashi Y; Funai K; Eto F; Mizuno K; Kawase A; Tao H; Kitamoto T; Takahashi Y; Sugimura H; Setou M; Kahyo T; Shiiya N
    BMC Cancer; 2021 Nov; 21(1):1232. PubMed ID: 34789180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
    Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
    Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
    Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
    Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer.
    Shin JY; Yoon JK; Marwaha G
    Lung; 2018 Jun; 196(3):351-358. PubMed ID: 29550987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key.
    Kaur H; Sehgal IS; Bal A; Gupta N; Behera D; Das A; Singh N
    Indian J Cancer; 2017; 54(1):285-290. PubMed ID: 29199707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.
    Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):566-73. PubMed ID: 24570559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma.
    Li J; Chen H; Li X; Wang L; Gao A; Zhang P; Lin W; Gao W; Yang D; Guo X; Liu J; Dang Q; Sun Y
    Mol Med Rep; 2017 Aug; 16(2):1643-1652. PubMed ID: 28656229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma.
    Zhang Y; Hu C
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):454-461. PubMed ID: 27801732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the Clinicopathological Characteristics and Prognosis of Patients with Nonurothelial Bladder Cancer.
    Ren H; Wang K; Liu C
    Arch Esp Urol; 2024 Mar; 77(2):148-157. PubMed ID: 38583007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
    Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
    Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    Huang JY; Jian ZH; Ndi Nfor O; Jhang KM; Ku WY; Ko PC; Jan SR; Ho CC; Lung CC; Pan HH; Liang YC; Liaw YP
    PLoS One; 2015; 10(7):e0133367. PubMed ID: 26196516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
    Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival analysis of patients with non-small cell lung cancer complicated with type 2 diabetes mellitus.
    Wang G; Li X; Xiong R; Wu H; Xu M; Xie M
    Thorac Cancer; 2020 May; 11(5):1309-1318. PubMed ID: 32190995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.